Network Partners

Partner   Division Scientist in charge
Universität Osnabrück
/ DE		 Molecular Membrane Biology prof. dr. Joost Holthuis
network coordinator
Universiteit Utrecht
/ NL		 Bijvoet Center prof. dr. Albert Heck
Weizmann Institute of Science
/ IL		 Molecular Genetics dr. Maya Schuldiner
Université de Geneve
/ CH		 Biochemistry prof. dr. Howard Riezman
University College London
/ UK		 Institute of Ophthalmology dr. Tim Levine
Ecole Polytechnique Federale de Lausanne
/ CH		 Laboratory of Protein Engineering prof. dr. Kai Johnsson
Laboratory of Therapeutic Proteins & Peptides prof. dr. Christian Heinis
University of Oxford
/ UK		 Department of Pharmacology prof. dr. Frances Platt
European Molecular Biology Laboratory
/ DE		 Cell Biology and Biophysics Unit dr. Carsten Schultz
Intana Bioscience
/ DE		   dr. Stefan Hannus
Sirius Fine Chemicals GmbH
/ DE		   dr. Hartmut Gillandt

 

Recent News

Three Sphingonet partners (EMBL ,UU & UOS) deliver "Hot paper" in Angewandte Chemie:
 Haberkant et al. published the paper "In Vivo Profiling and Visualization of Cellular Protein-Lipid interactions Using Bifunctional Fatty acids" .
The development of this technique paves the way for studying sphingolipid-protein interactions. Research in this direction is ongoing!
 

Recent Events

April 5th, 2013: Approval of progress report year 1
The EU approved our progress report, acknowledging the work progress and achievement of several milestones. This sets the standard for the upcoming reporting events.

Upcoming Events

  • 11 - 13 July  2013, Oxford
    - Summer School, including workshop From Bench to Bedside - Pre-clinical research (Organiser: Frances Platt)
    - Plenary meetings of the Consortium (PIs) and Young Research Council (fellows)
  • 30 September - 4 October 2013, Utrecht
    Mass spectrometry course, definitive program tba
  • (4-6) November 2013, Heidelberg
    Course: photoactivatable proteins and lipids, definitive dates and times tba
  • 7 & 8 November 2013, Heidelberg
    Mid-term review meeting

Fellowships

  • ESR1: “Mapping ceramide homeostatic machinery involved in programmed cell death” [more]
  • ESR2: “Evaluation of sphingolipid homeostatic machinery as target for modulating drug-induced apoptosis in tumors” [more]
  • ESR3: “Identification of cross-talk between sphingolipid and phosphoprotein signaling pathways” [more]
  • ESR4: “Tracing novel mediators of sphingolipid homeostasis using high-throughput visual screens” [more]
  • ESR5: “Tracing novel mediators of sphingolipid homeostasis using toxic peptide reagents” [more]
  • ESR6: “Mechanism of sphingolipid traffic at membrane contact sites” [more]
  • ESR7: “Development and application of semi-synthetic sphingolipid sensors” [more]
  • ESR8: “Generation of peptide ligands to sphingolipids and regulators of sphingolipid homeostasis” [more]
  • ESR9: “Niemann-Pick type C disease: pathogenesis and therapy” [more]
  • ESR10 “Chemical methods to manipulate sphingolipid pools in live cells” [more]
  • ER1: “Development of a novel drug target-profiling platform in yeast” [more]
  • ER2: “Enabling FCCS-based affinity measurements of membrane-drug interactions” [more]

Funded by

  Cordis FP7-People

  Marie Curie Actions

 European Union

User login